Artiklar med krav på offentlig åtkomst - Avinash SahuLäs mer
Inte tillgänglig någonstans: 1
Chromosome 7 gain compensates for chromosome 10 loss in glioma
NU Nair, AA Schäffer, EM Gertz, K Cheng, J Zerbib, AD Sahu, G Leor, ...
Cancer Research 84 (20), 3464-3477, 2024
Krav: European Commission
Tillgängliga någonstans: 36
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
P Jiang, S Gu, D Pan, J Fu, A Sahu, X Hu, Z Li, N Traugh, X Bu, B Li, J Liu, ...
Nature medicine 24 (10), 1550-1558, 2018
Krav: US National Institutes of Health
Therapeutically increasing MHC-I expression potentiates immune checkpoint blockade
SS Gu, W Zhang, X Wang, P Jiang, N Traugh, Z Li, C Meyer, B Stewig, ...
Cancer discovery 11 (6), 1524-1541, 2021
Krav: US National Institutes of Health, Wellcome Trust
Gut microbiota dependent anti-tumor immunity restricts melanoma growth in Rnf5−/− mice
Y Li, R Tinoco, L Elmén, I Segota, Y Xian, Y Fujita, A Sahu, R Zarecki, ...
Nature communications 10 (1), 1492, 2019
Krav: US National Institutes of Health
Targeting the Warburg effect via LDHA inhibition engages ATF 4 signaling for cancer cell survival
G Pathria, DA Scott, Y Feng, J Sang Lee, Y Fujita, G Zhang, AD Sahu, ...
The EMBO journal 37 (20), e99735, 2018
Krav: US National Institutes of Health
Harnessing synthetic lethality to predict the response to cancer treatment
JS Lee, A Das, L Jerby-Arnon, R Arafeh, N Auslander, M Davidson, ...
Nature communications 9 (1), 2546, 2018
Krav: US National Science Foundation, US National Institutes of Health, Cancer …
Evolution of delayed resistance to immunotherapy in a melanoma responder
D Liu, JR Lin, EJ Robitschek, GG Kasumova, A Heyde, A Shi, A Kraya, ...
Nature medicine 27 (6), 985-992, 2021
Krav: US National Science Foundation, Swiss National Science Foundation, US …
Translational reprogramming marks adaptation to asparagine restriction in cancer
G Pathria, JS Lee, E Hasnis, K Tandoc, DA Scott, S Verma, Y Feng, ...
Nature cell biology 21 (12), 1590-1603, 2019
Krav: US National Institutes of Health, Fonds de recherche du Québec - Santé
Comprehensive map of age-associated splicing changes across human tissues and their contributions to age-associated diseases
K Wang, D Wu, H Zhang, A Das, M Basu, J Malin, K Cao, S Hannenhalli
Scientific reports 8 (1), 10929, 2018
Krav: US National Science Foundation, US National Institutes of Health
Cell-free DNA captures tumor heterogeneity and driver alterations in rapid autopsies with pre-treated metastatic cancer
B Pereira, CT Chen, L Goyal, C Walmsley, CJ Pinto, I Baiev, R Allen, ...
Nature communications 12 (1), 3199, 2021
Krav: US National Institutes of Health
Immune receptor repertoires in pediatric and adult acute myeloid leukemia
J Zhang, X Hu, J Wang, AD Sahu, D Cohen, L Song, Z Ouyang, J Fan, ...
Genome medicine 11, 1-11, 2019
Krav: US National Institutes of Health, National Natural Science Foundation of …
Distal CpG islands can serve as alternative promoters to transcribe genes with silenced proximal promoters
S Sarda, A Das, C Vinson, S Hannenhalli
Genome research 27 (4), 553-566, 2017
Krav: US National Institutes of Health
CRISPR screens decode cancer cell pathways that trigger γδ T cell detection
MR Mamedov, S Vedova, JW Freimer, AD Sahu, A Ramesh, MM Arce, ...
Nature 621 (7977), 188-195, 2023
Krav: US National Science Foundation, US National Institutes of Health, Dutch …
ChIPnorm: a statistical method for normalizing and identifying differential regions in histone modification ChIP-seq libraries
NU Nair, AD Sahu, P Bucher, BME Moret
Public Library of Science 7 (8), e39573, 2012
Krav: Swiss National Science Foundation
Beyond synthetic lethality: charting the landscape of pairwise gene expression states associated with survival in cancer
A Magen, AD Sahu, JS Lee, M Sharmin, A Lugo, JS Gutkind, AA Schäffer, ...
Cell reports 28 (4), 938-948. e6, 2019
Krav: US National Science Foundation, US National Institutes of Health
A landscape of response to drug combinations in non-small cell lung cancer
NU Nair, P Greninger, X Zhang, AA Friedman, A Amzallag, E Cortez, ...
Nature Communications 14 (1), 3830, 2023
Krav: US National Institutes of Health, Wellcome Trust
Migration rather than proliferation transcriptomic signatures are strongly associated with breast cancer patient survival
NU Nair, A Das, VM Rogkoti, M Fokkelman, R Marcotte, CG de Jong, ...
bioRxiv 9 (1), 10989, 2018
Krav: US National Science Foundation, US National Institutes of Health
Genome‐wide prediction of synthetic rescue mediators of resistance to targeted and immunotherapy
A Sahu, JS Lee, Z Wang, G Zhang, R Iglesias‐Bartolome, T Tian, Z Wei, ...
bioRxiv, 2018
Krav: US National Institutes of Health
Bayesian integration of genetics and epigenetics detects causal regulatory SNPs underlying expression variability
A Das, M Morley, CS Moravec, WHW Tang, H Hakonarson, ...
Nature communications 6 (1), 8555, 2015
Krav: US National Institutes of Health
CRISPR screens identify essential cell growth mediators in BRAF inhibitor-resistant melanoma
Z Li, B Wang, S Gu, P Jiang, A Sahu, CH Chen, T Han, S Shi, X Wang, ...
Genomics, Proteomics and Bioinformatics 18 (1), 26-40, 2020
Krav: US National Institutes of Health, National Natural Science Foundation of China
Publikations- och finansieringsuppgifter tas fram automatiskt av ett datorprogram.